Utility of Serial Donor-derived Cell-free DNA Measurements for Detecting Allograft Rejection in a Kidney Transplant Recipient After PD-1 Checkpoint Inhibitor Administration
| Autor: | Laila Lakhani, MD, Sami Alasfar, MD, Anshul Bhalla, MD, Amtul Aala, MD, Avi Rosenberg, MD, Darin Ostrander, PhD, Megan D. Schollenberger, CRNP, Daniel C. Brennan, MD, Evan J. Lipson, MD |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Transplantation Direct, Vol 7, Iss 2, p e656 (2021) |
| Druh dokumentu: | article |
| ISSN: | 2373-8731 00000000 02840545 |
| DOI: | 10.1097/TXD.0000000000001113 |
| Popis: | Background. Donor-derived cell-free DNA (dd-cfDNA) is a useful biomarker of rejection that originates from allograft cells undergoing injury. Plasma levels |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|